Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting

被引：1

作者：

Fougerousse, A. -C. ^{[1
]}

Maccari, F. ^{[2
]}

Beauchet, A. ^{[3
,4
]}

Parier, J. ^{[2
]}

Boulard, C. ^{[5
]}

Becherel, P. -A. ^{[6
]}

Quiles-Tsimaratos, N. ^{[7
]}

Le Guyadec, T. ^{[8
]}

Thomas-Beaulieu, D. ^{[9
]}

Halioua, B. ^{[10
]}

Begon, E. ^{[11
]}

Bastien, M. ^{[12
]}

Perrot, J. -L. ^{[13
]}

Pallure, V. ^{[14
]}

Bilan, P. ^{[15
]}

Steff, M. ^{[15
]}

Pfister, P. ^{[10
]}

Vermersch-Langlin, A. ^{[16
]}

Boye, T. ^{[17
]}

Mery-Bossard, L. ^{[18
]}

Maillard, H. ^{[19
]}

Kemula, M. ^{[10
]}

Girard, C. ^{[20
]}

Poiraud, C. ^{[21
]}

Monfort, J. -B. ^{[22
]}

Kupfer-Bessaguet, I. ^{[23
]}

Perrussel, M. ^{[24
]}

Lons-Danic, D. ^{[25
]}

Sultan, N. ^{[26
]}

Lorier, E. ^{[10
]}

Zeitoun, M. ^{[27
]}

Wagner, L. ^{[10
]}

Gabison, G. ^{[28
]}

Mahe, E. ^{[29
]}

机构：

[1] Hop Instruct Armees Begin, Dept Dermatol, St Mande, France

[2] Private Off, La Varenne St Hilaire, France

[3] Univ Paris Saclay, CHU Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne, France

[4] Univ Paris Saclay, UVSQ, Boulogne, France

[5] Hop Havre, Dept Dermatol, Montivilliers, France

[6] Hop Prive Antony, Dept Dermatol, Antony, France

[7] Hop St Joseph, Dept Dermatol, Marseille, France

[8] Hop Instruct Armees Percy, Dept Dermatol, Clamart, France

[9] Ctr Hosp Intercommunal Poissy St Germain Laye, Dept Dermatol, Poissy, France

[10] Private Off, Paris, France

[11] Hop Rene Dubos, Dept Dermatol, Pontoise, France

[12] Private Off, Joinville Le Pont, France

[13] CHU St Etienne, Dept Dermatol, St Etienne, France

[14] Ctr Hosp, Dept Dermatol, Perpignan, France

[15] Ctr Hosp Robert Ballanger, Dept Dermatol, Aulnay Sous Bois, France

[16] Ctr Hosp, Dept Dermatol, Valenciennes, France

[17] Hop Instruct Armees St Anne, Dept Dermatol, Toulon, France

[18] Ctr Hosp Francois Quesnay, Dept Dermatol, Mantes La Jolie, France

[19] Ctr Hosp, Dept Dermatol, Le Mans, France

[20] CHU St Eloi, Dept Dermatol, Montpellier, France

[21] Ctr Hosp, Dept Dermatol, La Roche Sur Yon, France

[22] CHU Tenon, Dept Dermatol, Paris, France

[23] Ctr Hosp, Dept Dermatol, Niort, France

[24] Private Off, Auray, France

[25] Hop St Joseph, Dept Dermatol, Paris, France

[26] Ctr Hosp Gabriel Martin, Dept Dermatol, St Paul, France

[27] Private Off, Antony, France

[28] Private Off, St Maurice, France

[29] Hop Victor Dupouy, Dept Dermatol, Argenteuil, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 12期

关键词：

EXPERIENCE; SURVIVAL;

D O I：

10.1111/jdv.15804

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E476 / E478

页数：3

共 50 条

[1] Real-world experience of apremilast as a treatment choice for chronic plaque psoriasis from a district general hospital setting
Hadjieconomou, S.
Hughes, J.
Kamath, S.
Li, V.
Rajan, S.
Haebich, G.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (01) : E36 - E37
[2] Comment on "Drug survival of apremilast for psoriasis in a real-world setting"
Santos-Juanes, Jorge
Velasco, Lucia
Munguia-Calzada, Pablo
Lozano, Ana
Gomez-Diez, Santiago
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E83 - E84
[3] Repy to: "Comment on 'Drug survival of apremilast for psoriasis in a real-world setting'"
Lee, Erica B.
Amin, Mina
Wu, Jashin J.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E85 - E85
[4] Drug survival of apremilast in patients treated for psoriasis in a real-world setting
Lee, Erica B.
Amin, Mina
Wu, Jashin J.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : 760 - 761
[5] Comparison of the real-world costs associated with different treatment patterns in adults initiating apremilast or biologics for the treatment of psoriasis
Feldman, Steven
Bonafede, Machaon
Pelletier, Corey
Mehta, Rina
Wilson, Kathleen
Smith, David
Brouillette, Matthew
Li, Qing
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB84 - AB84
[6] Adverse events associated with apremilast use and withdrawal for psoriasis in a real-world setting
Lee, E. B.
Amin, M.
Egeberg, A.
Wu, J. J.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (10) : E393 - E394
[7] Real-World Experience With Apremilast in Treating Psoriasis
Mayba, Julia N.
Gooderham, Melinda J.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2017, 21 (02) : 145 - 151
[8] Apremilast in psoriasis - a prospective real-world study
Vujic, I.
Herman, R.
Sanlorenzo, M.
Posch, C.
Monshi, B.
Rappersberger, K.
Richter, L.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S195 - S195
[9] Apremilast in psoriasis - a prospective real-world study
Vujic, I.
Herman, R.
Sanlorenzo, M.
Posch, C.
Monshi, B.
Rappersberger, K.
Richter, L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (02) : 254 - 259
[10] Real-world treatment patterns of adults with psoriasis initiated on apremilast or biologics
Wu, Jashin J.
Wang, Ann
Jobson, Greeta
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101

← 1 2 3 4 5 →